Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary: objectives The kinetic basis for the effect of type 2 diabetes mellitus (DM) on postprandial lipoproteins has not been fully established. We investigated chylomicron remnant metabolism using a stable isotope breath test and fasting measurements of plasma apolipoprotein (apo) B‐48 and apoC‐III concentrations in postmenopausal women with and without type 2 DM. patients Twenty‐four postmenopausal women without DM and 14 postmenopausal women with diet‐controlled DM of similar age and body mass index (BMI) were studied in the postabsorptive state. methods The fractional catabolic rate (FCR) of an intravenously injected chylomicron remnant‐like emulsion was determined from the appearance of 13 CO 2 in the breath using isotope‐ratio mass spectrometry and multicompartmental modelling. apoB‐48, a marker of particle number of intestinal lipoproteins, was determined immunoelectrophoretically. apoC‐III was measured by immunoturbidimetric assay. results Compared with the nondiabetic women, the women with DM had significantly higher plasma apoB‐48 concentration (16·40 ± 1·18 mg/l vs. 13·0 ± 0·9 mg/l; mean ± standard error mean; P = 0·021), higher plasma apoC‐III concentration (204·24 ± 15·18 mg/l vs. 170·74 ± 10·75 mg/l; P = 0·042) and lower FCR of the chylomicron remnant‐like emulsion (0·06 ± 0·05 pools/h vs. 0·12 ± 0·02 pools/h; P < 0·001). In the diabetic patients, the FCR of the emulsion was correlated significantly with plasma apoB‐48 levels (r = −0·641, P = 0·007) but not with apoC‐III levels. conclusions In postmenopausal women, diabetes mellitus appears to decrease the catabolism of chylomicron remnants and result in an accumulation of these particles in plasma. This may chiefly be due to decreased clearance by hepatic receptors related to an effect of insulin resistance. Impairment in the catabolism of chylomicron remnants may contribute to increased risk of atherosclerosis in postmenopausal women with type 2 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
Shachter, N. S. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00009 · Cited by 288
Li, W. W., Dammerman, M. M., Smith, J. D., Metzger, S., Breslow, J. L., & Leff, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118324 · Cited by 278 · cited 2×
“Experimental work also suggests that in type 2 DM, chylomicron triglyceride content is increased rather than an increase in apoB-48 production (Gleeson et al., 1999). apoC-III expression is partly regulated by insulin (Li et al., 1995).”
BackgroundBlaak, E. E., van Aggel-Leijssen, D. P., Wagenmakers, A. J., Saris, W. H., & van Baak, M. A. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2102 · Cited by 178 · cited 1×
“Moreover, in type 2 DM total body fatty acid oxidation is unaltered and in fact the oxidation of esterified fatty acids is increased (Blaak et al., 2000), which would potentially result in an apparent increase in the catabolism of remnants measured by the breath test.”
Background
Cited by
Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease
Chait, A., Ginsberg, H. N., Vaisar, T., Heinecke, J. W., Goldberg, I. J., & Bornfeldt, K. E. (2020) · Diabetes · doi:10.2337/dbi19-0007 · Cited by 229
“Accordingly, in postmenopausal women, diabetes has been shown to decrease the catabolism of chylomicron-derived RLPs, resulting in accumulation of RLPs in plasma (62).”
BackgroundAn ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
Chan, D. C., Chen, M. M., Ooi, E. M. M., & Watts, G. F. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01678.x · Cited by 85
Self-citationRecent insights into factors affecting remnant lipoprotein uptake
Williams, K. J., & Chen, K. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328338cabc · Cited by 91
Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance
Whyte, M. B., Shojaee-Moradie, F., Sharaf, S. E., Jackson, N. C., Fielding, B., Hovorka, R., Mendis, J., Russell-Jones, D., & Umpleby, A. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01176 · Cited by 32
Metadata
- Authors
- Dane‐Stewart, C. A., Watts, G. F., Barrett, P. H. R., Stuckey, B. G. A., Mamo, J. C. L., Martins, I. J., & Redgrave, T. G.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2003-03-18
- Volume
- 58
- Issue
- 4
- Pages
- 415-420
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2131216254
- Cited by
- 42
- References
- 3
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus. https://app.cochat.ai/papers/10.1046/j.1365-2265.2003.01731.x
- The paper
- Dane‐Stewart, C. A., Watts, G. F., Barrett, P. H. R., Stuckey, B. G. A., Mamo, J. C. L., Martins, I. J., & Redgrave, T. G. (2003). Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2003.01731.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.